TransMedics Group Inc (TMDX)
US Market

TransMedics Group (TMDX) Stock Price & Analysis


TMDX Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$10.00 - $70.20
Previous Close$69.36
Average Volume (3M)344.68K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$204.46M
Total Debt (Recent Filing)$67.73M
Price to Earnings (P/E)-46.5
Next EarningsMar 06, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
EPS (TTM)-1.49
Shares Outstanding31,924,220
Standard Deviation0.23
10 Day Avg. Volume402,691
30 Day Avg. Volume344,675
Price to Book (P/B)10.71
Price to Sales (P/S)33.60
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-39.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside-5.20% Downside
Rating ConsensusStrong Buy
Number of Analyst Covering4



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was TransMedics Group’s price range in the past 12 months?
TransMedics Group lowest stock price was $10.00 and its highest was $70.20 in the past 12 months.
    What is TransMedics Group’s market cap?
    Currently, no data Available
    When is TransMedics Group’s upcoming earnings report date?
    TransMedics Group’s upcoming earnings report date is Mar 06, 2023 which is in 30 days.
      How were TransMedics Group’s earnings last quarter?
      TransMedics Group released its earnings results on Nov 03, 2022. The company reported -$0.25 earnings per share for the quarter, beating the consensus estimate of -$0.412 by $0.162.
        Is TransMedics Group overvalued?
        According to Wall Street analysts TransMedics Group’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does TransMedics Group pay dividends?
          TransMedics Group does not currently pay dividends.
          What is TransMedics Group’s EPS estimate?
          TransMedics Group’s EPS estimate is -$0.3.
            How many shares outstanding does TransMedics Group have?
            TransMedics Group has 31,924,220 shares outstanding.
              What happened to TransMedics Group’s price movement after its last earnings report?
              TransMedics Group reported an EPS of -$0.25 in its last earnings report, beating expectations of -$0.412. Following the earnings report the stock price went up 23.997%.
                Which hedge fund is a major shareholder of TransMedics Group?
                Among the largest hedge funds holding TransMedics Group’s share is Driehaus Capital Management LLC. It holds TransMedics Group’s shares valued at 42M.


                  TransMedics Group Stock Smart Score

                  The TransMedics Group stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  TransMedics Group Inc

                  TransMedics Group, Inc. is a commercial stage medical technology company, which engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in October 2018 and is headquartered in Andover, MA.


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  PROCEPT BioRobotics

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis